Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617.

The oncologist·2026
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

<sup>18</sup>F-Fluciclovine or <sup>68</sup>Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial.

Radiology·2026
Same author

High-speed optical tracking and augmented reality platform for image-guided interventions.

Journal of medical imaging (Bellingham, Wash.)·2026
Same author

Bladder activity of different PSMA PET radioligands and impact of furosemide.

American journal of nuclear medicine and molecular imaging·2026
Same author

Response to the Comment on "Negative 18 F-FES PET/CT Despite Estrogen Receptor Positivity By Immunohistochemistry."

Clinical nuclear medicine·2026

Related Experiment Video

Updated: May 19, 2026

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

Hyperspectral imaging and quantitative analysis for prostate cancer detection.

Hamed Akbari1, Luma V Halig, David M Schuster

  • 1Emory University, Department of Radiology and Imaging Sciences, Atlanta, Georgia 30329, USA.

Journal of Biomedical Optics
|August 17, 2012
PubMed
Summary

Hyperspectral imaging (HSI) offers a noninvasive method for prostate cancer detection. This advanced technique accurately differentiates cancerous from healthy tissue, aiding surgical precision.

More Related Videos

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Related Experiment Videos

Last Updated: May 19, 2026

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Area of Science:

  • Medical imaging
  • Optical diagnostics
  • Biomedical engineering

Background:

  • Hyperspectral imaging (HSI) is an emerging technology with potential for noninvasive medical diagnostics.
  • Quantitative analysis of spectral data is crucial for distinguishing healthy from diseased tissue.
  • Prostate cancer detection can benefit from advanced image processing techniques.

Purpose of the Study:

  • To develop and evaluate an advanced image processing and classification method for prostate cancer detection using HSI.
  • To analyze spectral signatures of cancerous and normal prostate tissue.
  • To assess the efficacy of least squares support vector machines (LS-SVM) for HSI data classification in cancer detection.

Main Methods:

  • Extraction and evaluation of spectral signatures from cancerous and normal tissues.
  • Development and application of LS-SVM for classifying HSI data.
  • Detection of prostate cancer in tumor-bearing mice and on pathology slides.
  • Generation of spatially resolved images to visualize tissue reflectance differences.

Main Results:

  • LS-SVM demonstrated effectiveness in classifying HSI data for cancer detection.
  • Preliminary results in 11 mice showed high sensitivity (92.8% ± 2.0%) and specificity (96.9% ± 1.3%).
  • Spatially resolved images highlighted distinct reflectance properties between cancerous and normal tissues.

Conclusions:

  • The proposed HSI method shows significant potential for accurate and noninvasive prostate cancer diagnosis.
  • This technology could assist physicians in precisely dissecting malignant regions and evaluating tumor beds post-resection.
  • Further advancements in optical diagnosis of prostate cancer using HSI are anticipated.